ACTIVE

PHARMACIE DE LA GRAND RUE

Financial year 2025 · Closed on 31/12/2025

Net result153,4 k €-2,8 %over 1 year
Gross margin431,9 k €-1,0 %over 1 year
Equity660 k €+30,3 %over 1 year
Workforce2,9 ETP-6,5 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE DE LA GRAND RUE is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe. It employs on average 2,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0846.815.047
Incorporation
25/06/2012
Legal form
Private limited company
Registered office
Rue des Canadiens 24
7180 Seneffe · WallonieSee on map
Contributed capital
107 640,00 €
Latest accounts
31/12/2025
Average workforce
2,9 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 14 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin431,9 k €436,1 k €464 k €429,5 k €464,3 k €
EBITDA212,2 k €231,8 k €269,4 k €257,9 k €306,9 k €
Operating result194,8 k €220,2 k €250,7 k €221,8 k €264,4 k €
Net result153,4 k €157,8 k €191,4 k €148,1 k €188,1 k €
Balance sheet
Equity660 k €506,5 k €348,7 k €157,4 k €139,3 k €
Total assets1,1 M €906,3 k €727,3 k €646,6 k €1 M €
Cash531,3 k €436,5 k €328,2 k €267,6 k €237,3 k €
Debts418,3 k €399,8 k €378,6 k €489,2 k €866 k €
Other
Workforce2,9 ETP3,1 ETP2,9 ETP4,9 ETP2,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 01 octobre 2016 · 0506.893.294

Represented by Anne André

Active

Ended mandates

DEVANTHINIC PHARMA

Manager · since 01 octobre 2016 · 0506.893.294

Represented by ANNE ANDRE

Ended
ANNE ANDRE

Manager · until 30 septembre 2016

Ended
ANNE ANDRE

Manager

Ended

Other companies at this address

Rue des Canadiens 24 7180 Seneffe
CompanyCBE no.
1039.753.688
0506.893.294
MARIEC.C-PHARMA● Active
0507.640.788
PHAMALIMO● Active
0846.675.386
0478.484.667
0458.492.472
0432.058.190
0421.582.883
0872.063.652
0477.710.053
PHARMA-LOUVE● Active
0894.160.549

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/08/202625/08/202526/08/202431/07/202326/08/202227/08/2021
General meeting31/07/202631/07/202531/07/202430/06/202317/05/202218/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202531/07/202624/08/2026FrenchPDF
Abridged model31/12/202431/07/202525/08/2025FrenchPDF
Abridged model31/12/202331/07/202426/08/2024FrenchPDF
Abridged model31/12/202230/06/202331/07/2023FrenchPDF
Abridged model31/12/202117/05/202226/08/2022FrenchPDF
Abridged model31/12/202018/05/202127/08/2021FrenchPDF
Abridged model31/12/201919/05/202005/10/2020FrenchPDF
Abridged model31/12/201821/05/201909/09/2019FrenchPDF
Abridged model31/12/201715/05/201813/07/2018FrenchPDF
Abridged model31/12/201616/05/201708/08/2017FrenchPDF
Abridged model31/12/201517/05/201617/08/2016FrenchPDF
Abridged model31/12/201419/05/201514/08/2015FrenchPDF
Abridged model31/12/201320/05/201419/08/2014FrenchPDF
Abridged model31/12/201221/05/201327/06/2013FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 01 octobre 2016 · 0506.893.294

Represented by Anne André

Active

Ended mandates

DEVANTHINIC PHARMA

Manager · since 01 octobre 2016 · 0506.893.294

Represented by ANNE ANDRE

Ended
ANNE ANDRE

Manager · until 30 septembre 2016

Ended
ANNE ANDRE

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other28/09/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF
  • Mandates07/02/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Other04/07/2012
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025153,4 k €↓
  2. 2024
    Annual accounts 2024157,8 k €↓
  3. 2023
    Annual accounts 2023191,4 k €↑
  4. 2023
    Name changePHARMACIE DE LA GRAND RUE
  5. 2022
    Annual accounts 2022148,1 k €↓
  6. 2021
    Annual accounts 2021188,1 k €↓
  7. 2021
    Name changeGrand Rue
  8. 2020
    Annual accounts 2020198 k €↑
  9. 2019
    Annual accounts 201951,2 k €↓
  10. 2018
    Annual accounts 201869,9 k €↑
  11. 2017
    Annual accounts 201734,3 k €↑
  12. 2016
    Annual accounts 201617,9 k €↓
  13. 2015
    Annual accounts 2015114,9 k €↑
  14. 2014
    Annual accounts 201498,1 k €↑
  15. 2013
    Annual accounts 201351,5 k €
  16. 25/06/2012
    IncorporationPrivate limited company